Baird analyst Matthew Gillmor raised his price target for The Advisory Board (ABCO) to $65 from $57 after Bloomberg reported the company is near a deal to split up and sell its Healthcare business to UnitedHealth (UNH) and Education business to Vista Equity. The analyst views the split as "a best case scenario for the stock." Further, the reported $1.5B valuation for Education is "substantially higher" than prior estimates, Gillmor tells investors in a research note. The deal reported by Bloomberg "significantly" increases the probability that Advisory Board could realize greater than $60 per share, the analyst adds. He keeps an Outperform rating on the shares.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Biohaven Pharmaceutical... To see the rest of the story go to thefly.com. See Story Here

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here